Related Experiment Video
Updated: Jun 30, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Persistent dystonia induced by fluoxetine
12nd Neurology Department of Ankara Numune Training and Research Hospital, Ankara, Turkey. sulebilen@gmail.com
Serotonin-selective re-uptake inhibitors (SSRIs) can cause extrapyramidal symptoms. This case study details persistent dystonia linked to short-term fluoxetine use, treated successfully with botulinum toxin type A.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Medicine
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed antidepressants.
- SSRIs are favored over older antidepressants like tricyclics and monoamine oxidase inhibitors due to perceived milder side-effect profiles.
- Despite their popularity, adverse effects of SSRIs, including extrapyramidal symptoms, are gaining attention.
Related Concept Videos
Alterations in Muscle Tone ll
Alterations in Muscle Tone lll
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Tetanus
